middle.news
ECS Botanics Fuels UWA Study on Medicinal Cannabis for Sleep Apnoea
9:30am on Monday 7th of July, 2025 AEST
•
Healthcare
Read Story
ECS Botanics Fuels UWA Study on Medicinal Cannabis for Sleep Apnoea
9:30am on Monday 7th of July, 2025 AEST
Key Points
ECS Botanics to provide Avani THC10 capsules for UWA-led clinical trial
Trial investigates 10mg THC effects on obstructive sleep apnoea severity
Randomised, double-blind study enrolling 24 participants in 2025
Focus on physiological mechanisms and next-day cognitive performance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ECS BOTANICS HOLDINGS (ASX:ECS)
OPEN ARTICLE